Dr Reddy’s Laboratories Q3 FY11 Results : Turnaround in Profit

by khalid on 26/01/2011 · 0 comments

No.1 pharmaceutical company in India, Dr Reddy’s Laboratories Limited has posted a consolidated net profit for the period Q3 (ending Dec 10) of the current fiscal (FY10-11). During the said quarter, consolidated net profit rose to Rs 273.14 crores in comparison to Rs (521.70) crores loss of Q3 (ending Dec 09) of previous year (FY09-10). Dr. Reddy’s Laboratories is an integrated pharmaceutical company focused on providing medicines through its three business segments: Global Generics segment, Pharmaceutical Services and Active Ingredients (PSAI) segment and Proprietary Products segment.

The company informed the share market (BSE/NSE) that the total income rose 9.82% to Rs 1918.30 crore in Q3 (ending Dec 2010) of the current fiscal (FY10-11) when compared with the same quarter Q3 (ending Dec 2009) of previous year (FY09-10). Total income was Rs 1746.78 crores in last year’s quarter Q3.

Share’s Data :-
BSE Code : 500164
Mkt. Cap : Rs 26,802.97 Crores
Dr Reddy’s Laboratories Ltd. share’s CMP is Rs 1,584.10 on 25th Jan 2011.

Stay tuned to BelltheBull Blog for more news on Dr Reddy’s Laboratories Limited !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: